Renata Pasqualini has been named chief scientific officer of New York-based PhageNova Bio. Pasqualini is a founder of the company, which recently changed its name from AAVP Biosystems. She is a professor and the chief of the division of cancer biology in the department of radiation oncology at the Rutgers Cancer Institute. Preclinical-stage PhageBio is developing targeted gene therapies to treat cancer.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
